Objectives: This study sought to describe the use of CRT-D and its association with survival
for older patients. Background: Many patients who receive cardiac resynchronization …

Aims Randomized controlled trials have shown that cardiac resynchronization therapy
(CRT) prolongs survival in patients with heart failure. No studies have explored survival after …

Background: Randomized control trials comparing the effectiveness of cardiac
resynchronization therapy devices, with (CRT-D) or without (CRT-P) a defibrillator, are …

Background Cardiac resynchronization with defibrillators (CRT-D) reduces heart failure and
mortality compared with defibrillators alone. Whether this applies to all ages is unclear …

Aims Mortality after cardiac resynchronization therapy (CRT) is difficult to predict. We sought
to design and validate a simple prognostic score for patients implanted with CRT, based on …

Introduction Older patients may be less likely to receive cardiac resynchronisation therapy
(CRT) for the management of heart failure. We aimed to describe the differences in clinical …

Heart failure (HF) affects 1–2% of the population in developed countries, with a higher
prevalence in patients> 70 years old. These figures are likely to increase in the near future …

Background Evidence regarding the incremental benefit of cardiac resynchronization
therapy (CRT) with a defibrillator (CRT‐D) versus without (CRT‐P) in elderly patients with …

Aims Cardiac resynchronization therapy (CRT) device implantation has been shown to
reduce morbidity and mortality in selected patients with heart failure. We sought to …

Background Defibrillators with cardiac resynchronisation therapy (CRT-Ds) are widely used
in patients with left ventricular (LV) systolic dysfunction and high-grade intraventricular …